These 5 Dividend Stocks Are Money-Printing Machines

The article reviews dividend sustainability and portfolio changes at five consumer companies. McCormick's proposed nearly $45 billion combination with Unilever's food business would create a company with more than $20 billion in annual sales; Colgate-Palmolive is exploring sales of brands for more than $1 billion combined. Altria's NJOY products were removed from shelves after an import ban, while Hershey paused dividend increases for nearly two years amid record-high cocoa costs and resumed growth as costs eased; its CFO cited visibility into cocoa deflation next year.

Analysis

The key distinction is between cash generation and the durability of the next cash engine. For KO and CL, portfolio discipline may improve returns on marketing and management attention, but small tests and asset sales are not earnings catalysts until they show up in repeat purchases, mix, or margins. CL’s sale process could also reveal whether supposedly lower-priority brands still attract strategic buyers; weak bids would challenge the assumed value of the remaining portfolio. For UL, a food-business disposal could simplify the story, but proceeds allocation and the earnings left behind matter more than the headline sale price.

MKC has the largest execution gap: combining businesses can diversify demand, but scale does not guarantee incremental cash flow after financing, integration costs, and any required portfolio changes. Verify deal terms, funding, pro forma leverage, and closing conditions before paying for the projected sales base.

HSY offers a conditional earnings inflection, not a clean commodity call: cocoa-price relief reaches reported costs with a lag, and pricing, volumes, and hedging can offset it. The market may be underestimating the time needed for relief to reach margins. MO’s cash yield is less protective if the smoke-free transition remains concentrated in a product category exposed to regulatory decisions. Near term, deal terms and cocoa/commodity updates are the catalysts; over 6–18 months, integration and evidence of replacement growth matter. The article’s dividend framing is not itself a valuation signal.

Key Decisions for Investors

• Relative-value watch: favor HSY over MO on a confirmed easing-cocoa and margin-recovery path, rather than buying either solely for its dividend. Build only after HSY guidance or reported costs validate pass-through; reverse if cocoa costs reaccelerate or margins fail to improve. MO’s high yield is a counterweight, so size the pair modestly.
• Keep MKC on watch, not as an automatic deal-driven long. Reassess after financing, pro forma leverage, integration costs, and closing conditions are disclosed; avoid adding if leverage or earnings dilution is materially worse than expected. A delayed or failed transaction would remove the diversification thesis.
• For CL and KO, treat divestiture and product-testing claims as execution options, not near-term earnings upgrades. Look for evidence in organic growth, product mix, and margins before changing exposure; for CL, also monitor sale proceeds use and whether the process attracts credible bids.
• For UL, assess the food-business sale on retained earnings quality and capital allocation, not proceeds alone. A weak price, unfavorable terms, or poor deployment of cash would undermine the simplification thesis.